Managing multiple cardiovascular risk factors

Journal of Family Practice,  March, 2008  by Roy C. Blank,  Stephen Brunton

• E-mail
• Print
• Link

(26.) LaRosa JC, Grundy SM, Waters DD, et al, for the Treating to New Targets (TNT) Investigations. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352:1425-1435.

(27.) Kostis JB, Breazno A, LaRosa JC, et al. The benefits of intensive lipid lowering in patients with stable CHD and systolic blood pressure above or below 140 mm Hg: a post-hoc analysis of the TNT study. J Clin Hypertens. 2006;8:455 (abstract).

(28.) Chapman RH, Benner JS, Petrilla AA, et al. Predictors of adherence with antihypertansive an lipid-lowering therapy. Arch Intern Med. 2005;165:1147-1152.

(29.) Brookhart MA, Patrick AR, Schneeweiss S, et al. Physician fellow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use. Arch Intern Med. 2007;167:847-852.

(30.) Munger MA, Van Tassell BW, LaFleur J. Medication nonadherence: an unrecognized cardiovascular risk factor. Med Gan Med. 2007;9:58.

(31.) Bangalore S, Kamalakkannan G, Parkar S, et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007;120: 713-719.

Roy C. Blank, MD Southern Piedmont Primary Care Monroe, North Carolina

Stephen Brunton, MD, FAAFP Director, Faculty Development Cabarrus Family Medicine Residency Program Concord, North Carolina

Address correspondence to: Stephen Brunton, MD 12105 Copper Way, Suite 202 Charlotte, NC 28277 E-mail: sbrunton@pceconsortium.org